IMMUPHARMAIMMUPHARMAIMMUPHARMA

IMMUPHARMA

No trades
See on Supercharts

IMM.GB fundamentals

An in-depth look to IMMUPHARMA operating, investing, and financing activities

IMM.GB free cash flow for H2 24 is -891.62 k GBP. For 2024, IMM.GB free cash flow was -1.77 M GBP and operating cash flow was -1.76 M GBP.

Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: GBP
TTM
Free cash flowYoY growth